title: Infliximab-induced palmoplantar psoriasis in a patient with ankylosing spondylitis.
authors.forename: Erhan
authors.initials: E
authors.lastname: Capkin
authors.forename: Murat
authors.initials: M
authors.lastname: Karkucak
authors.forename: Savaş
authors.initials: S
authors.lastname: Yayli
authors.forename: Arzu
authors.initials: A
authors.lastname: Aydin Çapkin
authors.forename: Mehmet
authors.initials: M
authors.lastname: Tosun
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D005528:Foot; D006225:Hand; D006801:Humans; D000069285:Infliximab; D011565:Psoriasis / Q000139:chemically induced* / Q000175:diagnosis; D013167:Spondylitis, Ankylosing / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab